NCT04823000View on ClinicalTrials.gov

Effects of Repeated Mesenchymal Stem Cells (MSC) in Patients With Progressive Multiple Sclerosis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 1, 2013

Primary Completion Date

December 1, 2016

Study Completion Date

April 1, 2020

Conditions
Multiple Sclerosis
Interventions
BIOLOGICAL

Mesenchymal Stem Cells (MSC)

Repeated intrathecal and intravenous injection of autologous mesenchymal stem cells (1 million cells per Kg of body weight) at 6 months intervals.

All Listed Sponsors
lead

Hadassah Medical Organization

OTHER

NCT04823000 - Effects of Repeated Mesenchymal Stem Cells (MSC) in Patients With Progressive Multiple Sclerosis | Biotech Hunter | Biotech Hunter